You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Musculoskeletal conditions
  5. Arthritis

Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal)

  • Technology appraisal
  • Reference number: TA302
  • Published:  27 November 2013
  • Guidance
  • Tools and resources
  • History

Juvenile idiopathic arthritis (systemic) - canakinumab (terminated appraisal): appendix B - GE Proposal Paper January 2015

Juvenile idiopathic arthritis (systemic) - canakinumab (terminated appraisal): appendix B - GE Proposal Paper January 2015 Juvenile idiopathic arthritis (systemic) - canakinumab (terminated appraisal): appendix B - GE Proposal Paper January 2015
02 February 2015
(239.02 Kb 9 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 29 January 2015

Back to top